Trial intelligence / Profile preview

Low vs intermediate IV dexamethasone doses on rebound pain after ambulatory foot surgery

2025-523356-31-01Phase 4Authorised

Sponsor
Hospital Universitario Doctor Peset
Start
Dec 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexamethasone in postoperative pain (2 arms), sponsored by Hospital Universitario Doctor Peset. Primary endpoint: Incidence of rebound pain. Planned start Dec 2025; status: authorised.

02

Drugs

dexamethasone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2025-523356-31-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2025-523356-31-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call